Modifier Q0- Investigational Clinical Service

Identifies an investigational clinical service provided as part of an approved clinical research study, including qualifying Medicare clinical trials and certain approved studies.

Home > All Categories > Medicare Modifiers > Modifier Q0

Modifier Q0 identifies an investigational clinical service provided in an approved clinical research study.

An investigational clinical service is generally an item or service being investigated as an objective of the study. The service may itself be approved, unapproved, covered, or otherwise noncovered outside the research context, depending on the applicable Medicare coverage requirements.

Modifier Q0 was introduced effective January 1, 2008, replacing the former QA and QR modifiers. CMS continues to recognize Q0 in current Medicare clinical-research billing guidance.

Q0 is closely related to Modifier Q1, but the two serve different purposes. Q0 identifies the investigational service, while Q1 identifies qualifying routine clinical services associated with an approved clinical research study.

When to Use Modifier Q0

Investigational Service: The item or service is being investigated as an objective of the clinical research study.

Approved Clinical Research Study: The service is furnished within a study that satisfies applicable Medicare requirements.

Coverage With Evidence Development: Q0 may be required for certain services furnished under CMS Coverage with Evidence Development requirements.

Category B IDE Study: Q0 is used in applicable Medicare billing situations involving Category B investigational device exemption studies. CMS's current claims manual specifically instructs providers to use Q0 for qualifying Category B IDE devices.

Claim Requirements Are Met: Any additional diagnosis, clinical trial identifier, condition code, or other required claim information is correctly reported.

When NOT to Use Modifier Q0

Routine Clinical Service: Use Modifier Q1 when the service represents qualifying routine patient care associated with an approved clinical research study rather than the investigational service itself.

Service Is Unrelated to the Study: Do not append Q0 merely because the patient happens to participate in a clinical trial.

Study Does Not Qualify: Q0 does not make a service payable when the underlying study or service fails applicable Medicare coverage requirements.

Inpatient HCPCS Reporting Does Not Apply: CMS notes that Q0/Q1 HCPCS modifier requirements used for outpatient clinical-trial reporting do not apply to inpatient claims where HCPCS codes are not reported.

Historical QA Reporting: Do not use the discontinued Modifier QA for current Category B IDE services. CMS replaced QA with Q0 effective January 1, 2008.

Billing Example

A Medicare beneficiary participates in an approved clinical research study evaluating an investigational service.

The service being investigated as an objective of the study is reported with the appropriate CPT or HCPCS code and Modifier Q0 when required by Medicare.

The provider also reports any other required clinical-trial claim information, such as the applicable diagnosis code and clinical trial identifier.

This distinguishes the investigational service from qualifying routine clinical services associated with the study, which may instead require Modifier Q1.

Documentation Requirements

Study Participation: Document that the beneficiary is participating in the applicable approved clinical research study.

Investigational Service: Clearly identify the item or service being investigated as part of the study.

Study Information: Maintain documentation identifying the applicable clinical trial, registry, IDE, or other approved research program.

Clinical Trial Identifier: Report and maintain the required clinical trial identification information when applicable.

Medical Record: Documentation should establish the relationship between the reported service and the clinical research study.

Coverage Requirements: Maintain evidence supporting compliance with applicable Medicare clinical-trial or Coverage with Evidence Development requirements.

Billing and Claim Considerations

Clinical research claims can require more information than Modifier Q0 alone.

For example, current CMS billing guidance for certain Coverage with Evidence Development services requires ICD-10-CM Z00.6, Modifier Q0, and the applicable clinical trial identifier on professional claims. Institutional outpatient claims may additionally require Condition Code 30 and other study-identification information.

The exact requirements depend on the clinical trial, service, claim type, and applicable Medicare coverage policy.

Providers should therefore verify the relevant NCD, CED policy, Medicare Claims Processing Manual instructions, and MAC guidance before submitting a research-related claim.

Modifier Q0 itself does not guarantee Medicare payment. The study, beneficiary, service, and claim must satisfy all applicable Medicare coverage and billing requirements.

Common Billing Mistakes

Confusing Q0 With Q1: Q0 identifies the investigational clinical service, while Q1 generally identifies qualifying routine clinical services associated with the research study.

Using Q0 for Every Trial-Related Service: Not every service furnished to a clinical-trial participant is investigational.

Missing Clinical Trial Information: Failing to report a required clinical trial identifier can cause claim-processing problems.

Missing Z00.6: Certain Medicare clinical-research claims require ICD-10-CM Z00.6 to identify participation in a clinical research program.

Using Discontinued Modifier QA: QA was replaced by Q0 for applicable services beginning January 1, 2008.

Assuming Q0 Creates Coverage: The modifier identifies the service's research status but does not override Medicare coverage requirements.

Common Denial Reasons

Study Does Not Qualify: The clinical research study does not satisfy applicable Medicare requirements.

Incorrect Modifier: The service represents routine clinical care and should have been reported under the applicable Q1 requirements rather than Q0.

Missing Trial Identifier: Required clinical trial identification information is absent or incorrect.

Missing Claim Elements: Required diagnosis codes, condition codes, or other research-related billing information are missing.

Service Not Supported as Investigational: Documentation does not establish that the reported service is being investigated as part of the study.

Coverage Requirements Not Met: The beneficiary, study, or service does not satisfy the applicable Medicare coverage policy.

CMS currently warns in specific CED billing guidance that claims missing required clinical-research billing elements may be rejected as unprocessable or denied.

Modifier Q0 vs. Modifier Q1

Modifier Q0: Identifies an investigational clinical service provided in an approved clinical research study.

Modifier Q1: Identifies a routine clinical service provided in an approved clinical research study.

The key distinction is the role of the service in the research study.

If the item or service is itself being investigated as an objective of the study, Q0 may apply. If it represents qualifying routine patient care associated with participation in the study, Q1 may apply.

Frequently Asked Questions

Did Modifier Q0 replace Modifier QA?
Yes. CMS replaced QA and QR with Modifier Q0 effective January 1, 2008. QA should not be used for current claims.

Does every service provided during a clinical trial require Modifier Q0?
No. Q0 identifies investigational clinical services. Qualifying routine clinical services associated with an approved clinical research study are generally distinguished with Modifier Q1 when applicable.